Loading viewer...
earnings
Format: PDF earnings
Creo Medical Group plc presents FY2023 financial results and FY2024 outlook, highlighting total sales of £30.8m and 2.5x revenue increase from Speedboat Inject and CROMA products. The company achieved 49.6% gross margin and reduced underlying operating losses, with strong Q1-24 trading and growing consumables sales supporting continued growth plans.
earnings
23 Pages
Natera, Inc.
Trellidor Holdings 2024 Half Year Results Presentation
earningsearnings
25 Pages
Trellidor Holdings Limited
American Electric Power Q3 2021 Earnings Report
earningsearnings
9 Pages
American Electric Power